SUBSCRIBE
SUBSCRIBE
News   Business

CytRx Corporation RNAi Subsidiary, RXi Pharmaceuticals, Names Leader in RNAi Therapeutics to Its Scientific Advisory Board

April 9, 2007 | 
1 min read
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation’s (NASDAQ:CYTR) majority-owned subsidiary, RXi Pharmaceuticals Corporation (RXi), today announced that Dr. Nassim Usman has joined its scientific advisory board.
People
MORE ON THIS TOPIC
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong
Strong Business Partnership and teamwork metaphor as two different groups joining together with a handshake represented by trees and stronk roots.
Deals
Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal
June 26, 2025
 · 
1 min read
 · 
Annalee Armstrong
World heart day. Sketch style human heart. Retro halftone hands reaching out to each other. Modern collage. Valentines day banner. Healthcare medical concept. Healthy lifestyle.
Cardiovascular disease
Novartis Makes Potential $750M+ Bet Per Cardiovascular Disease Target in Another Flagship Pact
June 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Bayer’s BlueRock Lays Off 50 in Streamlining Effort
June 26, 2025
 · 
148 min read
 · 
BioSpace Editorial Staff